Surgery Partners, Inc. (NASDAQ:SGRY) Shares Sold by Aigen Investment Management LP

Aigen Investment Management LP lowered its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRYFree Report) by 60.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 7,923 shares of the company’s stock after selling 11,955 shares during the period. Aigen Investment Management LP’s holdings in Surgery Partners were worth $253,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of SGRY. Wellington Management Group LLP grew its position in shares of Surgery Partners by 23.2% during the third quarter. Wellington Management Group LLP now owns 8,022,700 shares of the company’s stock worth $234,664,000 after buying an additional 1,511,396 shares in the last quarter. Clearbridge Investments LLC lifted its stake in Surgery Partners by 4.7% in the fourth quarter. Clearbridge Investments LLC now owns 5,525,671 shares of the company’s stock worth $176,766,000 after acquiring an additional 247,762 shares during the last quarter. Invesco Ltd. grew its holdings in Surgery Partners by 9.3% during the 3rd quarter. Invesco Ltd. now owns 3,604,357 shares of the company’s stock worth $105,427,000 after acquiring an additional 305,216 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Surgery Partners by 8.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,840,212 shares of the company’s stock valued at $58,870,000 after purchasing an additional 149,146 shares during the last quarter. Finally, Deerfield Management Company L.P. Series C acquired a new stake in shares of Surgery Partners in the 3rd quarter valued at $42,705,000.

Insider Buying and Selling at Surgery Partners

In other news, CEO Jason Eric Evans sold 1,984 shares of the company’s stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $29.44, for a total transaction of $58,408.96. Following the completion of the sale, the chief executive officer now owns 464,510 shares in the company, valued at $13,675,174.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 2.30% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on the company. StockNews.com raised Surgery Partners from a “sell” rating to a “hold” rating in a report on Thursday, March 21st. Benchmark reissued a “buy” rating and set a $50.00 target price on shares of Surgery Partners in a research report on Wednesday, May 1st. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a report on Wednesday, April 10th. Citigroup cut their price objective on shares of Surgery Partners from $42.00 to $38.00 and set a “buy” rating on the stock in a report on Wednesday, May 8th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $49.00 target price on shares of Surgery Partners in a report on Thursday, February 29th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $43.13.

Read Our Latest Analysis on Surgery Partners

Surgery Partners Stock Up 3.9 %

Shares of NASDAQ:SGRY opened at $25.39 on Monday. Surgery Partners, Inc. has a 1-year low of $22.05 and a 1-year high of $45.79. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.71 and a quick ratio of 1.56. The stock has a market cap of $3.23 billion, a P/E ratio of 29.52, a P/E/G ratio of 2.01 and a beta of 2.75. The firm has a fifty day moving average price of $26.44 and a 200 day moving average price of $29.99.

Surgery Partners (NASDAQ:SGRYGet Free Report) last released its quarterly earnings results on Tuesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. The firm had revenue of $717.40 million for the quarter, compared to analyst estimates of $707.66 million. Surgery Partners had a return on equity of 3.65% and a net margin of 0.02%. Sell-side analysts predict that Surgery Partners, Inc. will post 0.84 EPS for the current year.

About Surgery Partners

(Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Featured Stories

Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRYFree Report).

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.